• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国北卡罗来纳州社区相关艰难梭菌感染的危险因素和估计发病率。

Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA.

机构信息

Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.

出版信息

Emerg Infect Dis. 2010 Feb;16(2):197-204. doi: 10.3201/eid1602.090953.

DOI:10.3201/eid1602.090953
PMID:20113547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2958012/
Abstract

We determined estimated incidence of and risk factors for community-associated Clostridium difficile infection (CA-CDI) among patients treated at 6 North Carolina hospitals. CA-CDI case-patients were defined as adults (>18 years of age) with a positive stool test result for C. difficile toxin and no hospitalization within the prior 8 weeks. CA-CDI incidence was 21 and 46 per 100,000 person-years in Veterans Affairs (VA) outpatients and Durham County populations, respectively. VA case-patients were more likely than controls to have received antimicrobial drugs (adjusted odds ratio [aOR] 17.8, 95% confidence interval [CI] 6.6-48] and to have had a recent outpatient visit (aOR 5.1, 95% CI 1.5-17.9). County case-patients were more likely than controls to have received antimicrobial drugs (aOR 9.1, 95% CI 2.9-28.9), to have gastroesophageal reflux disease (aOR 11.2, 95% CI 1.9-64.2), and to have cardiac failure (aOR 3.8, 95% CI 1.1-13.7). Risk factors for CA-CDI overlap with those for healthcare-associated infection.

摘要

我们确定了在北卡罗来纳州的 6 家医院接受治疗的患者中社区获得性艰难梭菌感染 (CA-CDI) 的估计发病率和危险因素。CA-CDI 病例患者被定义为粪便检测出艰难梭菌毒素阳性且过去 8 周内无住院史的成年人 (>18 岁)。退伍军人事务部 (VA) 门诊患者和达勒姆县人群中的 CA-CDI 发病率分别为每 100000 人年 21 例和 46 例。VA 病例患者比对照组更有可能接受抗菌药物治疗(调整后的优势比[aOR]17.8,95%置信区间[CI]6.6-48),且近期有门诊就诊(aOR 5.1,95% CI 1.5-17.9)。与对照组相比,县病例患者更有可能接受抗菌药物治疗(aOR 9.1,95% CI 2.9-28.9),更有可能患有胃食管反流病(aOR 11.2,95% CI 1.9-64.2),并且更有可能患有心力衰竭(aOR 3.8,95% CI 1.1-13.7)。CA-CDI 的危险因素与医疗保健相关感染的危险因素重叠。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e1/2958012/ff2b02a11d3b/09-0953-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e1/2958012/ff2b02a11d3b/09-0953-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e1/2958012/ff2b02a11d3b/09-0953-F.jpg

相似文献

1
Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA.美国北卡罗来纳州社区相关艰难梭菌感染的危险因素和估计发病率。
Emerg Infect Dis. 2010 Feb;16(2):197-204. doi: 10.3201/eid1602.090953.
2
Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study.艰难梭菌毒素阳性腹泻的危险因素:一项基于人群的前瞻性病例对照研究。
Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2601-10. doi: 10.1007/s10096-012-1603-0. Epub 2012 Mar 23.
3
Comparing the epidemiology of community- and hospital-associated Clostridium difficile infections in Northern Ireland, 2012-2016: a population data linkage and case-case study.比较 2012-2016 年北爱尔兰社区和医院获得性艰难梭菌感染的流行病学:人群数据关联和病例对照研究。
Epidemiol Infect. 2019 Jan;147:e141. doi: 10.1017/S0950268819000414.
4
Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.退伍军人管理局医疗系统中氟喹诺酮类药物的使用与艰难梭菌相关疾病的风险因素
Clin Infect Dis. 2007 Nov 1;45(9):1141-51. doi: 10.1086/522187. Epub 2007 Sep 26.
5
Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.粪便毒素 A/B 酶免疫分析法诊断免疫抑制患者艰难梭菌感染的灵敏度低。
Clin Microbiol Infect. 2015 Nov;21(11):998.e9-998.e15. doi: 10.1016/j.cmi.2015.07.016. Epub 2015 Jul 29.
6
Identification of novel risk factors for community-acquired Clostridium difficile infection using spatial statistics and geographic information system analyses.使用空间统计和地理信息系统分析确定社区获得性艰难梭菌感染的新风险因素。
PLoS One. 2017 May 16;12(5):e0176285. doi: 10.1371/journal.pone.0176285. eCollection 2017.
7
Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.采用超敏定量免疫法比较有症状感染和无症状携带的成人艰难梭菌粪便毒素浓度。
Clin Infect Dis. 2019 Jan 1;68(1):78-86. doi: 10.1093/cid/ciy415.
8
Epidemiologic Trends in Clostridioides difficile Infections in a Regional Community Hospital Network.区域性社区医院网络中艰难梭菌感染的流行病学趋势。
JAMA Netw Open. 2019 Oct 2;2(10):e1914149. doi: 10.1001/jamanetworkopen.2019.14149.
9
Risk factors for Clostridioides difficile infection in hospitalized patients and associated mortality in Japan: a multi-centre prospective cohort study.日本住院患者艰难梭菌感染的危险因素及相关死亡率:一项多中心前瞻性队列研究。
J Hosp Infect. 2020 Mar;104(3):350-357. doi: 10.1016/j.jhin.2019.09.012. Epub 2019 Sep 19.
10
Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece.希腊住院炎症性肠病患者艰难梭菌感染的流行情况。
Eur J Gastroenterol Hepatol. 2019 Jul;31(7):773-776. doi: 10.1097/MEG.0000000000001414.

引用本文的文献

1
Understanding the implementation of antimicrobial stewardship in Utah community pharmacies.了解犹他州社区药房抗菌药物管理的实施情况。
JAC Antimicrob Resist. 2025 Sep 3;7(5):dlaf155. doi: 10.1093/jacamr/dlaf155. eCollection 2025 Oct.
2
Proton-pump inhibitors increase infection risk by altering pH rather than by affecting the gut microbiome based on a bioreactor model.基于生物反应器模型,质子泵抑制剂通过改变pH值而非影响肠道微生物群来增加感染风险。
Gut Microbes. 2025 Dec;17(1):2519697. doi: 10.1080/19490976.2025.2519697. Epub 2025 Jun 16.
3
Epidemiologic profile of community-acquired infections: a systematic review and meta-analysis.

本文引用的文献

1
Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions.加拿大曼尼托巴省采用临时监测定义对艰难梭菌感染进行基于人群的监测。
Infect Control Hosp Epidemiol. 2009 Oct;30(10):945-51. doi: 10.1086/605719.
2
Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands.荷兰社区获得性艰难梭菌感染的临床和微生物学特征。
Clin Microbiol Infect. 2009 Dec;15(12):1087-92. doi: 10.1111/j.1469-0691.2009.02853.x. Epub 2009 Jul 16.
3
Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review.
社区获得性感染的流行病学概况:一项系统评价和荟萃分析。
Epidemiol Infect. 2025 Mar 4;153:e46. doi: 10.1017/S0950268825000202.
4
Incidence of Infections in Republic of Korea: A Prospective Study With Active Surveillance vs. National Data From Health Insurance Review & Assessment Service.韩国感染发生率:主动监测与健康保险审查与评估服务国家数据的前瞻性研究。
J Korean Med Sci. 2024 Apr 1;39(12):e118. doi: 10.3346/jkms.2024.39.e118.
5
Economic Burden of Clostridioides difficile Infection in European Countries.欧洲国家艰难梭菌感染的经济负担。
Adv Exp Med Biol. 2024;1435:1-12. doi: 10.1007/978-3-031-42108-2_1.
6
Biogeographic distribution and molecular epidemiology of () in Western Australian soils.西澳大利亚土壤中()的生物地理分布和分子流行病学研究。
Appl Environ Microbiol. 2023 Oct 31;89(10):e0037923. doi: 10.1128/aem.00379-23. Epub 2023 Oct 12.
7
infection following dental antibiotic prescriptions in a cohort of US veterans.美国退伍军人队列中牙科抗生素处方后的感染。
Infect Control Hosp Epidemiol. 2023 Mar;44(3):494-496. doi: 10.1017/ice.2021.516. Epub 2022 Feb 21.
8
Prevalence, Molecular Characterization and Antimicrobial Susceptibility of Isolated from Pig Carcasses and Pork Products in Central Italy.意大利中部猪胴体和猪肉产品中 的流行情况、分子特征和药敏分析。
Int J Environ Res Public Health. 2021 Oct 29;18(21):11368. doi: 10.3390/ijerph182111368.
9
Effective inhibition of Clostridioides difficile by the novel peptide CM-A.新型肽 CM-A 有效抑制艰难梭菌。
PLoS One. 2021 Sep 13;16(9):e0257431. doi: 10.1371/journal.pone.0257431. eCollection 2021.
10
IL-16 and BCA-1 Serum Levels Are Associated with Disease Severity of Infection.白细胞介素-16和BCA-1血清水平与感染的疾病严重程度相关。
Pathogens. 2021 May 20;10(5):631. doi: 10.3390/pathogens10050631.
通过毒素检测试剂盒诊断艰难梭菌感染:一项系统评价
Lancet Infect Dis. 2008 Dec;8(12):777-84. doi: 10.1016/S1473-3099(08)70233-0. Epub 2008 Nov 1.
4
A case-control study of community-associated Clostridium difficile infection.一项关于社区相关性艰难梭菌感染的病例对照研究。
J Antimicrob Chemother. 2008 Aug;62(2):388-96. doi: 10.1093/jac/dkn163. Epub 2008 Apr 22.
5
Clostridium difficile-associated diarrhea: an emerging threat to pregnant women.
Am J Obstet Gynecol. 2008 Jun;198(6):635.e1-6. doi: 10.1016/j.ajog.2008.01.062. Epub 2008 Apr 8.
6
Surveillance for community-associated Clostridium difficile--Connecticut, 2006.2006年康涅狄格州社区相关性艰难梭菌监测
MMWR Morb Mortal Wkly Rep. 2008 Apr 4;57(13):340-3.
7
Incidence of Clostridium difficile infection in inflammatory bowel disease.炎症性肠病中艰难梭菌感染的发病率
Clin Gastroenterol Hepatol. 2007 Mar;5(3):339-44. doi: 10.1016/j.cgh.2006.12.027.
8
Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.质子泵抑制剂的使用与因口服万古霉素治疗处方所定义的社区获得性艰难梭菌相关疾病的风险
CMAJ. 2006 Sep 26;175(7):745-8. doi: 10.1503/cmaj.060284.
9
Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea.艰难梭菌毒素阳性医院内腹泻的危险因素
Int J Antimicrob Agents. 2006 Sep;28(3):231-7. doi: 10.1016/j.ijantimicag.2006.04.013.
10
Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003.1996 - 2003年美国短期住院医院出院患者的艰难梭菌感染情况
Emerg Infect Dis. 2006 Mar;12(3):409-15. doi: 10.3201/eid1205.051064.